Skip links

Onpattro® (patisiran)

Full Name Onpattro® (patisiran)
Drug Onpattro
Manufacturer Alnylam Pharmaceuticals
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication The treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults
Disease Hereditary ATTR amyloidosis (hATTR) – Polyneuropathy (PN)
Therapeutic Area Neurology
Enrollment Form Link Onpattro Start Form
Phone Number 800-690-8236
Fax Number 877-445-8481
Product Website